It is morally wrong to make a mother choose between treatment for herself and treatment for her newborn. It is morally wrong that people should be dying of AIDS when treatment is available.
It is morally wrong that babies are still being born with HIV when we know how to prevent it. It is morally wrong that children are still growing up as AIDS orphans.
To be a partner for women and girls against violence and injustice, you do not have to be experts on human rights or gender. You do have to be committed to always asking in your daily work: 'How can I better engage women and girls to understand what they need'
A society that cuts itself off from its youth severs its lifeline; it is condemned to bleed to death.
When the history of our times is written, will we be remembered as the generation that turned our backs in a moment of global crisis or will it be recorded that we did the right thing?
No disease group is as vast and complex in scope as the noncommunicable diseases (NCDs). Incorporating social determinants such as income and education, the NCDs call for an equally massive and comprehensive response
There are 1.2 billion adolescents across the world, 9 out of 10 of these young people live in developing countries. Millions are denied their basic rights to quality education, health care, protection and exposed to abuse and exploitation.
Of all the forms of inequality, injustice in health care is the most shocking and inhumane.
“The early years in a child’s life—when the human brain is forming—represent a critically important window of opportunity to develop a child’s full potential and shape key academic, social, and cognitive skills that determine a child’s success in school and in life.”—President Barack Obama
“If art is to nourish the roots of our culture, society must set the artist free to follow his vision wherever it takes him.”—President JF Kennedy
"The true character of a society is revealed in how it treats its children. History will judge us by the difference we make in the everyday lives of children."—President Nelson Mandela

Mentoring Program

What is the Issue or Problem?

Low and middle income countries (LMICs), who are also referred to as developing countries, bear the greatest burden of global communicable and non-communicable diseases affecting mothers, neonates, infants, children, and families as well as HIV/AIDS; however, very few research publications in reputable journals and development productivity come from researchers and scientists based in the developing countries. This gap has been attributed, in part, to lack of technical writing skills owing to limited access to state-of-the-art training and development opportunities in resource-limited countries. Some initiatives have been implemented to address the capacity of researchers and scientists in resource-limited countries, however, few practical steps and measurable actions have been taken to address this age-long problem in line with a measurable output. So the problem persists.

Our Solution

We know that academic publication in peer-reviewed journals is a key measure of research and development productivity. Unfortunately, we also know that many researchers in the developing countries have not done so well not because they cannot but because they have not been shown how to do better. To address this need, we have introduced our novel and signature International Journal of MCH and AIDS (IJMA) Peer Mentoring Program™ (IPMP). IPMP offers free and flexible manuscript development services to eligible researchers, scientists, and policy makers from developing countries. IPMP matches scientific research and development capacity building with a key measurable objective evidenced in the peer-reviewed publication in a reputable international journal. IPMP is at the core mission of IJMA—to contribute to the development of next generation of researchers and scientists from developing countries by building their capacity to publish high-quality papers in a reputable international peer-reviewed journal. This is our mission; this is our goal; and we have built our journal based on this philosophy.

Who is Eligible for IPMP?

The IPMP is limited to researchers and scientists from low and middle income countries (LMICs). We define LMICs according to World Bank’s classification. Please see here for the Bank’s definition and list of countries considered members of LMICs.

How Does the Program Work?

Researchers and scientists from developing countries may participate in the IPMP at two stages:

Stage 1: prior to submitting a manuscript for publication consideration in a peer-reviewed journal, or

Stage 2: after a manuscript submitted to IJMA is adjudged by the Editor-in-Chief and/or peer-reviewers to be of a quality that is only publishable with substantial revision.

When a researcher from a developing country is found eligible and agrees to participate in the IPMP, the IPMP Program Office applies a rigorous screening process to match the Research-Mentee with a Research-Mentor with substantial experience in academic publishing. Research Mentors may be based in the industrialized countries or in developing countries.

If the IPMP Program Office finds a suitable match, both the Research Mentor and Mentee will sign a Memorandum of Understanding in accordance with the rules and regulations guiding the IPMP program. After this, the program begins.

For more information about the IPMP see IPMP FAQs. 

IJMA Peer Mentoring Program – Frequently Asked Questions (FAQs)

Here are some of the most frequently asked questions (FAQs) about the International Journal of MCH and AIDS Peer Mentoring Program (IPMP).

Q: I’m worried about the confidentiality of my research ideas and manuscript. How do you maintain confidentiality of the process?

A: Every IPMP participant will sign a Memorandum of Understanding (MOU) with IJMA before participating in the program. The MOU contains a provision on confidentiality for Research Mentor and Research Mentee.

Q: Am I under obligation to publish the manuscript that I obtained IPMP assistance in your journal?

A: Yes, IPMP Research Mentees must publish the manuscript for which they received IPMP assistance in IJMA.

Q: How much does participation in IPMP cost?

A: There is no cost for participation in IPMP. IPMP is a free manuscript development assistance for researchers, scientists, and policy makers from developing countries. IPMP is a free contribution of IJMA, its parent organization, and our Research Mentors to developing research and development capacity in developing countries.

Q: Must your journal publish my manuscript if I participate in the IPMP?

A: No, participation in IPMP is NOT a guarantee that your manuscript will be published in IJMA. All manuscripts must go through the journal’s rigorous peer-review process.

Q: How does the IPMP really help me get published in IJMA?

A: IPMP will increase the odds of a paper’s acceptance for publication in IJMA because the Research Mentor assists the Research Mentee to address the specific weaknesses identified (or that will be potentially identified) in your manuscript by peer-reviewers.

Q: My field of study/research does not fall within the scope of your journal. Can I still participate in the IPMP?

A: No, IPMP is limited to researchers and scientists working in the fields within the scope of the journal. If you are in doubt, contact us via email info@mchandaids.org.

Q: I am a developing country graduate student working on my thesis/dissertation. Can IPMP help me?

A: No, IPMP is not for dissertation or thesis writing, it is only for manuscript preparation.

Q: I’m a researcher/scientist from LMIC based in developed country. Can I participate in IPMP?

A: No, our primary interest is for researchers based in LMICs where accesses to opportunities are limited. However, every case shall be considered on a case-by-case basis.

Q: How do I know if I’m eligible?

A: The IPMP matching process involves a screening process to test for eligibility.

Q: How much does it cost to participate in your IPMP? A: There is no payment for participating in the IPMP. Suggestions will be given to authors undergoing IPMP on best practices to acknowledge Mentor assistance in accordance with international best practices on contributions to academic research.

Q: I submitted a manuscript to IJMA, how would I know if I am referred to IPMP?

A: If your manuscript has been reviewed and recommended for IPMP, you will be notified via email.

Q: How long does the IPMP last? A: On the average, we expect the IPMP to last 12 months or less for one manuscript. But we ask that both parties be flexible.

Q: I’ve finished reading your FAQs, but I still have some questions. What should I do?

A: Please contact the IPMP Office in Washington, DC, USA, via email: info@mchandaids.org.

You can download the FAQ in pdf format here.

 

x
Message